Read the Leaflet Before You Swallow: The Honest Side Effects of Hiring a Social Media Agency

At The Social Clinic, we believe in informed consent. Before a brand signs a retainer, it deserves to know exactly what it's swallowing — the active ingredients, the recommended dosage, and yes, the side effects.

So consider this your patient information leaflet. Keep it handy. Consult it if symptoms persist.

Before You Take This Medication

A social media agency, when prescribed correctly, can treat a range of conditions: flat engagement, patchy posting, a feed that hasn't seen a pulse since last spring. But like any treatment, it works best when the patient understands what they're signing up for.

Most brands don't. They see the case studies, hear the pitch, sign on the dotted line, and discover six weeks later that 'community management' meant one person scheduling posts on a Tuesday afternoon.

Here's what the leaflet should say.

Common Side Effects (Usually Mild, Often Manageable)

Jargon-induced headaches. Expect regular exposure to terms like 'synergy', 'always-on strategy' and 'leveraging first-party data'. Most patients build a tolerance within a quarter. If the headaches worsen, ask your provider to explain things in plain English. A good one will. A bad one will send a slide deck.

Budget dizziness. That first month, when the retainer leaves the account and the results haven't arrived yet, can feel disorienting. This is normal. Results in social media are typically cumulative, like a course of antibiotics — stopping halfway through because you felt better (or didn't) is how brands relapse.

Mild dependency. After six months with a capable agency, many brands find they've forgotten how their own scheduling tool works. This is by design in some cases, and by accident in most. Regular handover notes and shared access can keep this side effect in check.

Content withdrawal symptoms. Some agencies will want to pull your brand voice apart and rebuild it. The first fortnight of new tone-of-voice guidelines can feel alien — like your brand has been on a detox retreat and come back with a new accent. Usually worth it. Occasionally not.

Meeting fatigue. Monthly reports, quarterly reviews, 'quick calls that overrun'. Most of it is genuinely useful; some of it is theatre. You're allowed to ask which is which.

Serious Side Effects (Seek Immediate Advice)

Some symptoms don't warrant a phone call — they warrant stopping the medication entirely.

Locked accounts. If your agency holds sole admin access to your profiles, your ad accounts and your pixel data, and resists sharing, that's not partnership. That's a hostage situation with nicer branding. You should be able to walk away with everything you own.

The vanishing results. Reports full of impressions and reach but silent on conversions, leads or sales? That's not reporting — that's anaesthetic. Numbing you while the underlying condition goes untreated.

Recycled treatment plans. If the strategy document for your artisan bakery reads suspiciously like the one for a B2B SaaS firm, you're being mass-prescribed. Insist on a bespoke diagnosis.

The unexplained fee. Retainers that quietly grow, 'media spend handling' percentages nobody explained, or line items labelled only as 'management' — these need unpacking before they metastasise.

Nobody can name your account manager. High staff turnover on your account means nobody's building knowledge of your brand. Continuity of care matters in medicine and marketing alike.

Dosage and Administration

The correct dose varies. A start-up might need a half-day audit and a content calendar. A national retailer might need full community management plus paid social. What doesn't vary: you should always know what you're getting, who's doing it, and how you'll know it's working.

Overdosing is a real risk too. Buying every service on the menu when your actual condition calls for one targeted treatment is how marketing budgets end up in A&E.

The Consultation Checklist: Questions to Ask Before You Sign

Print this. Take it to your next pitch meeting.

1. Who exactly will be working on our account — and can we meet them before signing? Not the founders. The people doing the work.

2. What does success look like in 90 days, in numbers we care about? If the answer is 'engagement', ask what engagement earns.

3. Who owns the accounts, assets and data? The answer must be: you, unconditionally, from day one.

4. What's the notice period, and what's included in the handover? A confident agency will have a clean exit process. A clingy one will get vague.

5. How do you report — and can we see a sample report from a real client? Anonymised, ideally. Check whether it leads with outcomes or activity.

6. What happens in the first 30 days? There should be a clear plan: audit, access, quick wins. Not 'we'll get our bearings'.

7. What will you need from us? Agencies can't treat a brand that won't take its own medicine. Approvals, brand assets and honest access all speed recovery.

8. Can we start with a smaller prescription? A project or audit before a 12-month retainer is a perfectly reasonable ask. Agencies confident in their outcomes won't flinch.

Final Words From the Consultant

Most agencies are competent, honest people doing genuinely difficult work in a channel that changes weekly. The horror stories come from brands that signed blind — no leaflet, no questions, no diagnosis before the prescription.

Don't be that patient. Read the label, ask the questions, and if a provider bristles at being asked, consider that your first symptom.

And if you'd like a second opinion before you sign anything? That's rather our specialty. Book in for a digital health check — no needle required.